REQUEST A DEMO
Total
USD $0.00
Search more companies

Newglab Pharma Co., Ltd. (South Korea)

Main Activities: Other Communications Equipment Manufacturing
Full name: Newglab Pharma Co., Ltd. Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Newglab Pharma Co., Ltd. is based in South Korea, with the head office in Bucheon. It operates in the Other Communications Equipment Manufacturing industry. The enterprise was incorporated on February 24, 2004. 15 (2023) employees currently work for Newglab Pharma Co., Ltd.. The latest financial highlights indicate a net sales revenue drop of 58.8% in Q3C2024. A negative growth of 48.44% was recorded in its total assets. In, 2024, the company’s net profit margin decreased by 109.03%.

Headquarters
23, Sinheung-Ro 362Beon-Gil, Bucheon-Si, Gyeonggi-Do
Bucheon; Gyeonggi;

Contact Details: Purchase the Newglab Pharma Co., Ltd. report to view the information.

Website: http://www.newglab.com

Basic Information
Total Employees:
Purchase the Newglab Pharma Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Newglab Pharma Co., Ltd. report to view the information.
Registered Capital:
Purchase the Newglab Pharma Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Newglab Pharma Co., Ltd. report to view the information.
Incorporation Date:
February 24, 2004
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
12%
Purchase this report to view the information.
4.9%
Subsidiaries
Aiting Art (Tianjin) Technology Co Ltd
100%
Newg Lab Pharma Inc
100%
뉴지랩파마코리아(주)
100%
Company Performance
Financial values in the chart are available after Newglab Pharma Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-58.8%
Total Operating Revenue
-57.83%
Operating Profit
N/A
EBITDA
31.32%
Net Profit/Loss for the Period
-28.53%
Total Assets
-48.44%
Total Equity
22.52%
Operating Profit Margin
N/A
Net Profit Margin
-109.03%
Return on Equity (ROE)
13.66%
Debt / Equity
53.42%
Quick Ratio
-0.12%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?